| 000 | 03220nam a2200433Ia 4500 | ||
|---|---|---|---|
| 001 | bslw08837371 | ||
| 003 | UtOrBLW | ||
| 005 | 20161010130651.0 | ||
| 006 | m d | ||
| 007 | cr un||||||||| | ||
| 008 | 121001s2012 enka o 000 0 eng d | ||
| 020 |
_a9781781901298 (electronic bk.) : _c£62.95 ; €89.95 ; $114.95 |
||
| 040 |
_aUtOrBLW _cUtOrBLW |
||
| 050 | 4 |
_aR855.3 _b.E26 2012 |
|
| 072 | 7 |
_aKCQ _2bicssc |
|
| 072 | 7 |
_aMBP _2bicssc |
|
| 072 | 7 |
_aMED003040 _2bisacsh |
|
| 072 | 7 |
_aBUS051000 _2bisacsh |
|
| 072 | 7 |
_aMED071000 _2bisacsh |
|
| 080 | _a608 | ||
| 082 | 0 | 4 |
_a610.28 _223 |
| 245 | 0 | 4 |
_aThe economics of medical technology _h[electronic resource] / _cedited by Kristian Bolin, Robert Kaestner. |
| 260 |
_aBingley, U.K. : _bEmerald, _c2012. |
||
| 300 |
_a1 online resource (xi, 198 p.) : _bill. |
||
| 490 | 1 |
_aAdvances in health economics and health services research, _x0731-2199 ; _vv. 23 |
|
| 505 | 0 | _aOverview / Kristian Bolin, Robert Kaestner -- Aspects of research and development contract terms in the bio/pharmaceutical sector / Tannista Banerjee -- Effects of regulation on drug launch and pricing in interdependent markets / Patricia M. Danzon, Andrew J. Epstein -- The effect of pharmaceutical innovation on the functional limitations of elderly Americans : evidence from the 2004 National Nursing Home Survey / Frank R. Lichtenberg -- Comparative effectiveness research, technological abandonment, and health care spending / David H. Howard, Yu-Chu Shen -- How do initial signals of quality influence the diffusion of new medical products? : the case of new cancer drug treatments / Rena M. Conti, Arielle Bernstein, David O. Meltzer -- Technology diffusion and substitution of medical innovations / Victoria Serra-Sastre, Alistair McGuire -- Health insurance and hospital technology adoption / Seth Freedman. | |
| 520 | _aMedical technology broadly defined to include all aspects of the process of treating disease (e.g., pharmaceuticals, medical devices, and surgical procedures) is profoundly important for individual health and, consequently, also for general welfare. Advances in medical technology convey the prospect of both improved population health and increased general welfare. However, because of the extensive regulation of the markets for healthcare goods and services, the development and application of medical technologies differs fundamentally from non-medical technological advances. In this volume of the Advances in Health Economics and Health Services Research series we present several papers that provide theoretical and empirical evidence about the market for medical technology. | ||
| 650 | 7 |
_aMedical _xAllied Health Services _xMedical Technology. _2bisacsh |
|
| 650 | 7 |
_aBusiness & Economics _xPublic Finance. _2bisacsh |
|
| 650 | 7 |
_aMedical _xPharmacology. _2bisacsh |
|
| 650 | 7 |
_aHealth economics. _2bicssc |
|
| 650 | 7 |
_aHealth systems & services. _2bicssc |
|
| 650 | 0 |
_aMedical technology _xEconomic aspects. |
|
| 700 | 1 | _aBolin, Kristian. | |
| 700 | 1 | _aKaestner, Robert. | |
| 776 | 1 | _z9781781901281 | |
| 830 | 0 |
_aAdvances in health economics and health services research ; _vv. 23. |
|
| 856 | 4 | 0 | _uhttp://www.emeraldinsight.com/0731-2199/23 |
| 999 |
_c1078 _d1078 |
||